Interaction between gut microbiota and immune checkpoint inhibitor-related colitis

Immune checkpoint inhibitors (ICIs) have become a promising therapeutic strategy for malignant tumors, improving patient prognosis, along with a spectrum of immune-related adverse events (irAEs), including gastrointestinal toxicity, ICI-related colitis (IRC), and diarrhea. The gut microbiota has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Guanzhou, Zhang, Nana, Meng, Ke, Pan, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648670/
https://www.ncbi.nlm.nih.gov/pubmed/36389768
http://dx.doi.org/10.3389/fimmu.2022.1001623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648670/
https://www.ncbi.nlm.nih.gov/pubmed/36389768
http://dx.doi.org/10.3389/fimmu.2022.1001623

Ejemplares similares